Haematology Events


The CLL Exchange: UK real-world evidence in CLL


Are you aware of UK real-world evidence in CLL? Hear from Dr Mark Raffety, Dr Dino Maw and Dr Faye Sharpley.





Found this useful? You might also be interested in:

 

The CLL Exchange:
Managing Cardiovascular
Comorbidities and Complications
in CLL

BSH Guidelines 2025 for the 1L
Treatment of CLL

Adverse events should be reported

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to AstraZeneca by visiting contactazmedical.astrazeneca.com or by calling 0800 783 0033.

September 2025 I GB-69434